Patent ID: 7626037

Claim:
A pharmaceutical composition containing at least one thiazolidin-4-one derivative of the Formula (I) wherein: R 1 represents lower alkyl, lower alkenyl; cycloalkyl; 5,6,7,8-tetrahydronaphth-1-yl; 5,6,7,8-tetrahydronaphth-2-yl; or an unsubstituted phenyl group; R 2 represents lower alkyl; allyl; cyclopropyl; cyclobutyl; cyclopentyl; or mono- or di-lower alkylamino; R 3 represents —O—CR 7 R 8 —CR 9 R 10 —(CR 11 R 12 ) n —O—R 13 ; R 4 represents hydrogen; hydroxy; lower alkoxy; lower alkyl; or halogen; R 5 and R 6 each represents independently lower alkyl; R 7 represents hydrogen, lower alkyl, or hydroxymethyl; R 8 , R 9 , R 11 and R 12 each represents independently hydrogen or methyl; R 10 represents hydrogen or lower alkyl; in case n represents the integer 1, R 10 in addition represents lower alkoxy, hydroxy, —NH 2 , —NHR 5 or —NR 5 R 6 ; R 13 represents hydrogen; lower alkyl; hydroxycarbonyl-lower alkyl; 1-glyceryl or 2-glyceryl; n represents the integer 0 or 1; in a configurational isomeric, an optically pure enantiomeric, a mixture of enantiomeric, an enantiomeric racemate, a diastereomeric, a mixture of diastereomeric, a diastereomeric racemate, a mixture of diastereomeric racemates, a meso-form, free or pharmaceutically acceptable salt form, and an inert carrier material.